Perm State Medicine Academy named after E.A.Vagner (PSMA)
Doctor of Medicine (MD), cum laude
1996 - 2003
Dmitry Zamoryakhin, Md, Mba's Summary
Dmitry Zamoryakhin, MD, MBA, based in London, GB, is currently a Chief Scientific Officer / Chief Medical Officer at Biodexa Pharmaceuticals PLC, bringing experience from previous roles at Midatech Pharma PLC, Freelance, Oxford Biomedica and Grünenthal Group. Dmitry Zamoryakhin, MD, MBA holds a 2022 - 2022 Harvard Medical School.